Edwards Lifesciences Corporation balance sheet
At the end of its fiscal year on Dec 31, 2025, Edwards Lifesciences Corporation reported total assets of $13.70B and shareholders' equity of $10.34B. That works out to liabilities equal to 25% of assets, a current ratio of 3.72 (current assets ÷ current liabilities), long-term debt of 0.06× shareholders' equity.
Balance sheet at each fiscal year end
| Fiscal year ended | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $4.51B | $5.67B | $5.32B | $6.49B | $7.24B | $8.50B | $8.29B | $9.36B | $13.06B | $13.70B |
| Current assets | $2.24B | $2.55B | $2.29B | $2.98B | $3.09B | $3.18B | $3.10B | $4.04B | $6.29B | $6.74B |
| Cash & equivalents | $930.10M | $818.30M | $714.10M | $1.18B | $1.18B | $862.80M | $769.00M | $1.13B | $3.05B | $2.94B |
| Total liabilities | — | — | — | — | $2.66B | $2.67B | $2.49B | $2.64B | $2.99B | $3.36B |
| Current liabilities | $532.50M | $1.42B | $876.60M | $902.40M | $893.90M | $1.03B | $1.02B | $1.20B | $1.51B | $1.81B |
| Long-term debt | $822.30M | $438.40M | $593.80M | $594.40M | $595.00M | $595.70M | $596.30M | $597.00M | $597.70M | $598.30M |
| Shareholders' equity | $2.62B | $2.96B | $3.14B | $4.15B | $4.57B | $5.84B | $5.81B | $6.65B | $10.00B | $10.34B |
| Reported in | 10-K 2018 | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 |
Balance-sheet figures are point-in-time values on the last day of each fiscal year. Some companies (for example banks and insurers) do not present current assets and liabilities; those cells show —.
Source: SEC EDGAR XBRL company facts for CIK 1099800 (raw data). Most recent filing in this dataset: 10-Q filed Aug 4, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.